Found 9 matching trials
Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh PHASE3 This protocol will evaluate the efficacy and safety of various combinations...
Show More Learn More & Join Trial
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis PHASE3 The overall objective of this trial is to identify a safe and effective com...
Show More Location
Kala-azar medical centre
Learn More & Join Trial
Combination Therapy in Indian Visceral Leishmaniasis PHASE3 Rationale
The overall objective of this trial is to identify a safe and ef...
Show More Location
Kala-azar Medical Research Center
Learn More & Join Trial
Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony PHASE2 Cutaneous leishmaniasis is endemic in the New World and, until recently, th...
Show More Learn More & Join Trial
Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. PHASE3 The overall objective of this trial is to identify a safe and effective tre...
Show More Learn More & Join Trial
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar PHASE2 Miltefosine and liposomal amphotericin B (AmBisome) are approved drugs for ...
Show More Location
Kala-azar Medical Research Center
Learn More & Join Trial
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ PHASE2 The purpose of this trial is to determine the efficacy and safety of a comb...
Show More Location
Programa de Estudios y Control de Enfermedades Tropicales (PECET), Universidad de Antioquia
Learn More & Join Trial
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis PHASE2 Cure rate for L braziliensis bolivian CL has been 70%-80% for standard syst...
Show More Location
Hopital, Dermatologico
Learn More & Join Trial
Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa PHASE2 This study is to assess if shorter combinations of SSG plus single dose AmB...
Show More Location
Kimalel Health Centre
Learn More & Join Trial